INCY Incyte Corporation
INCY Incyte Corporation
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $97.18 · VWAP $105.10 · +7.6% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster EVP, President sold $10.5M, Aug 4–14
Coverage
2 watchlists
INCY Price Structure
Loading timeframes…
Peers
Every watchlist INCY belongs to, members best 30-day change first — INCY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
Against street estimates
How INCY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about INCY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 8 days ago · Oct 9
INCY research tape
81 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.